These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1032568)

  • 1. The combined effect of propranolol with bethanidine or methyldopa in hypertension.
    Prichard BN
    Adv Clin Pharmacol; 1976; 11():107-13. PubMed ID: 1032568
    [No Abstract]   [Full Text] [Related]  

  • 2. A within-patient comparison of bethanidine, methyldopa and propranolol in the treatment of hypertension.
    Prichard BN; Boakes AJ; Graham BR
    Clin Sci Mol Med Suppl; 1976 Dec; 3():567s-570s. PubMed ID: 799566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-effect test of Xipamid in hypertension as compared with other antihypertensive drugs].
    Davies PS; Prichard BN
    Med Welt; 1976 Jun; 27(24):1204-8. PubMed ID: 781459
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hypertension with propranolol.
    Prichard BN; Gillam PM
    Br Med J; 1969 Jan; 1(5635):7-16. PubMed ID: 5761914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bethanidine, alpha-methyldopa, and reserpine in essential hypertension.
    Gibb WE; Malpas JS; Turner P; White RJ
    Lancet; 1970 Aug; 2(7667):275-7. PubMed ID: 4194359
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined dihydralazine and propranolol in the treatment of hypertension.
    Katila M; Frick MH
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):111-4. PubMed ID: 4924318
    [No Abstract]   [Full Text] [Related]  

  • 7. Bethanidine and oxprenolol in hypertension--a study in combination therapy.
    Rowlands G; McConachie NA; Currie WJ
    Practitioner; 1977 Jul; 219(1309):105-8. PubMed ID: 329261
    [No Abstract]   [Full Text] [Related]  

  • 8. Sotalol and bethanidine-an open general practice study in the combination therapy of hypertension.
    Rowlands G; McConachie NA; Currie WJ
    Br J Clin Pract; 1977 May; 31(5):57-9. PubMed ID: 884041
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyldopa and propranolol in moderate hypertension.
    Agarwal RK; Bhatnagar MK; Shukla SK; Gupta R; Dwivedi RN
    Indian Heart J; 1980; 32(1):13-5. PubMed ID: 7380450
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of combination of propranolol and hydralazine versus alpha-methyldopa in hypertension.
    Chopra BK
    J Assoc Physicians India; 1984 Sep; 32(9):811. PubMed ID: 6511772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of bethanidine sulfate in the treatment of arterial hypertension].
    Cristodorescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(4):279-89. PubMed ID: 778
    [No Abstract]   [Full Text] [Related]  

  • 14. Bethanidine vs Guanethidine.
    Raper AJ; Richardson DW
    Circulation; 1978 Apr; 57(4):841-3. PubMed ID: 343946
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 19. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
    Talbot S
    Cardiology; 1976; 61(4):254-66. PubMed ID: 13931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.